World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
53
Citations
9207
World Ranking
3999
National Ranking
28

Gunnar Kvalheim publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Gunnar Kvalheim sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 263 publications — 55th percentile

55% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Gunnar Kvalheim D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Gunnar Kvalheim sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 53 D-Index — 20th percentile

20% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Gunnar Kvalheim is affiliated with Oslo University Hospital in Norway. Their research focuses primarily on medicine, with a strong emphasis on immunology, microbiology, and biochemistry, genetics, and molecular biology. The scientist has contributed notably to multiple subfields, including oncology, immunology, molecular biology, pulmonary and respiratory medicine, and biomedical engineering.

Their research topics span several key areas in biomedical science and cancer therapy. These topics include:

  • CAR-T cell therapy research
  • Immunotherapy and immune responses
  • Cancer immunotherapy and biomarkers
  • RNA interference and gene delivery
  • Virus-based gene therapy research
  • Prostate cancer treatment and research
  • Nanowire synthesis and applications

Frequent coauthors collaborating with Kvalheim are:

  • Else Marit Inderberg
  • Sébastien Wälchli
  • Iris Bigalke
  • Dag Josefsen
  • Dolores J. Schendel

The scientist's publications appear in a number of journals, most notably:

  • Molecular Therapy
  • Nature Communications
  • Clinical & Translational Immunology
  • The Prostate
  • Leukemia

Selected recent papers by Gunnar Kvalheim include:

  • "Toll-like receptor 7/8-matured RNA-transduced dendritic cells as post-remission therapy in acute myeloid leukaemia: results of a phase I trial," 2020, Clinical & Translational Immunology
  • "ALPL-1 is a target for chimeric antigen receptor therapy in osteosarcoma," 2023, Nature Communications
  • "Long-term first-in-man Phase I/II study of an adjuvant dendritic cell vaccine in patients with high-risk prostate cancer after radical prostatectomy," 2021, The Prostate
  • "Targeting Telomerase with an HLA Class II-Restricted TCR for Cancer Immunotherapy," 2020, Molecular Therapy
  • "WT1 and PRAME RNA-loaded dendritic cell vaccine as maintenance therapy in de novo AML after intensive induction chemotherapy," 2023, Leukemia

Best Publications

  • Detection of Isolated Tumor Cells in Bone Marrow Is an Independent Prognostic Factor in Breast Cancer

    Gro Wiedswang;E. Borgen;R. Kåresen;Gunnar Kvalheim

  • Myelodysplastic Syndromes Are Propagated by Rare and Distinct Human Cancer Stem Cells In Vivo

    Petter S. Woll;Una Kjällquist;Onima Chowdhury;Helen Doolittle

  • Therapeutic vaccination against autologous cancer stem cells with mRNA-transfected dendritic cells in patients with glioblastoma.

    Einar Osland Vik-Mo;Marta Nyakas;Birthe Viftrup Mikkelsen;Birthe Viftrup Mikkelsen;Morten Carstens Moe

  • Telomerase peptide vaccination: a phase I/II study in patients with non-small cell lung cancer

    Paal F. Brunsvig;Steinar Aamdal;Marianne K. Gjertsen;Gunnar Kvalheim

  • Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. establishment of objective criteria for the evaluation of immunostained cells

    E. Borgen;B. Naume;J.M. Nesland;G. Kvalheim

  • Phase I/II trial of melanoma therapy with dendritic cells transfected with autologous tumor-mRNA.

    J. A. Kyte;L. Mu;Steinar Aamdal;Gunnar Kvalheim

  • Isolated tumor cells in bone marrow three years after diagnosis in disease-free breast cancer patients predict unfavorable clinical outcome.

    Gro Wiedswang;Elin Borgen;Rolf Kåresen;Hanne Qvist

  • High-dose therapy with autologous stem cell transplantation in patients with peripheral T cell lymphomas.

    A. K. Blystad;G. Enblad;S. Kvaløy;Å Berglund

  • Comparison of the clinical significance of occult tumor cells in blood and bone marrow in breast cancer.

    Gro Wiedswang;Elin Borgen;Cecilie Schirmer;Rolf Kåresen

  • Immunocytochemical detection of isolated epithelial cells in bone marrow: non-specific staining and contribution by plasma cells directly reactive to alkaline phosphatase.

    Elin Borgen;Klaus Beiske;Sissel Trachsel;Jahn M. Nesland

  • Identification and Characterization of Cells with Cancer Stem Cell Properties in Human Primary Lung Cancer Cell Lines

    Ping Wang;Quanli Gao;Zhenhe Suo;Zhenhe Suo;Else Munthe

  • Presence of bone marrow micrometastasis is associated with different recurrence risk within molecular subtypes of breast cancer

    Bjørn Naume;Xi Zhao;Marit Synnestvedt;Elin Borgen

  • Immunomagnetic techniques for the enrichment and detection of isolated breast carcinoma cells in bone marrow and peripheral blood.

    Bjorn Naume;Elin Borgen;Klaus Beiske;Tove Karin Herstad

  • Immunotherapy with allotumour mRNA-transfected dendritic cells in androgen-resistant prostate cancer patients

    L. J. Mu;J. A. Kyte;Gunnar Kvalheim;Steinar Aamdal

  • Depletion of T lymphocytes from human bone marrow: use of magnetic monosized polymer microspheres coated with T-lymphocyte-specific monoclonal antibodies

    Frode Vartdal;Gunnar Kvalheim;Tor E. Lea;Vidar Bosnes

  • Detection of cancer cells in effusions from patients diagnosed with gynaecological malignancies. Evaluation of five epithelial markers.

    Ben Davidson;Bjørn Risberg;Gunnar Kristensen;Gunnar Kvalheim

  • Detection of isolated tumor cells in bone marrow in early-stage breast carcinoma patients: Comparison with preoperative clinical parameters and primary tumor characteristics

    Bjørn Naume;Elin Borgen;Gunnar Kvalheim;Rolf Kåresen

  • hTERT mRNA dendritic cell vaccination: complete response in a pancreatic cancer patient associated with response against several hTERT epitopes.

    Else M.Inderberg Suso;Svein Dueland;Anne Marie Rasmussen;Turid Vetrhus

  • Increased sensitivity for detection of micrometastases in bone-marrow/peripheral-blood stem-cell products from breast-cancer patients by negative immunomagnetic separation.

    Bjørn Naume;Elin Borgen;Jahn M. Nesland;Klaus Beiske

  • Inclusion of an IgG1-Fc spacer abrogates efficacy of CD19 CAR T cells in a xenograft mouse model

    H Almåsbak;E Walseng;A Kristian;M R Myhre

  • A TCR-based Chimeric Antigen Receptor.

    Even Walseng;Hakan Köksal;Ibrahim M. Sektioglu;Anne Fåne

  • METHOD FOR DETECTION OF SPECIFIC TARGET CELLS AND MEANS FOR REALISATION

    Fodstad Oystein;Kvalheim Gunnar

Frequent Co-Authors

Gustav Gaudernack
Gustav Gaudernack Ultimovacs (Norway)
Jahn M. Nesland
Jahn M. Nesland Oslo University Hospital
Øystein Fodstad
Øystein Fodstad Oslo University Hospital
Erlend B. Smeland
Erlend B. Smeland Oslo University Hospital
Jan Delabie
Jan Delabie University Health Network
Wolfgang Hiddemann
Wolfgang Hiddemann Ludwig-Maximilians-Universität München
Alexander Pihl
Alexander Pihl University of Oslo
Baldur Sveinbjørnsson
Baldur Sveinbjørnsson University of Tromsø - The Arctic University of Norway
Sten Eirik W. Jacobsen
Sten Eirik W. Jacobsen University of Oxford

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, branching into advanced nursing roles can be a valuable pathway. Exploring which nurse practitioner program is easiest can help prospective students find programs that match their learning style and schedule.

Mental health is a growing field within nursing and healthcare. Programs like the top pmhnp programs offer specialized training in psychiatric mental health, often with strong clinical placement opportunities to gain real-world experience.

Cost is always a consideration. Identifying cheap psych np programs allows students to pursue psychiatric nurse practitioner degrees without overwhelming debt, making advanced education more accessible.

After earning a Doctor of Nursing Practice (DNP), understanding potential earnings is important. The dnp salary varies widely by location and specialization, offering insight into the financial benefits of these advanced degrees.

Best Scientists Citing Gunnar Kvalheim

Trending Scientists

Recently Published Articles